Trials / Completed
CompletedNCT00092716
Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)
A Multicenter, Double-Blind, Randomized, Parallel Group, 28-Week Study to Evaluate the Efficacy and Safety of Ezetimibe and Simvastatin Co-administration Versus Atorvastatin in Patients With Hypercholesteremia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 655 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether an investigational medication will be more effective than an approved medication in reducing cholesterol levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653, ezetimibe / Duration of Treatment: 28 weeks | |
| DRUG | Comparator: atorvastatin / Duration of Treatment: 28 weeks |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2003-04-01
- Completion
- 2003-04-01
- First posted
- 2004-09-28
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092716. Inclusion in this directory is not an endorsement.